Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Panitumumab MeSH Descriptor Data 2026


MeSH Heading
Panitumumab
Tree Number(s)
D12.776.124.486.485.114.224.060.864
D12.776.124.790.651.114.224.060.864
D12.776.377.715.548.114.224.200.864
Unique ID
D000077544
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077544
Scope Note
Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).
Entry Term(s)
ABX-EGF MAb
ABX-EGF Monoclonal Antibody
Panitumumab Antibody, Human
Vectibix
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
6A901E312A
0
CAS Type 1 Name
Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer
Public MeSH Note
2019; PANITUMUMAB was indexed under ANTIBODIES, MONOCLONAL 2005-2018
History Note
2019 (2005)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Panitumumab Preferred
Vectibix Narrower
page delivered in 0.153s